Patient Journey Guides

Parkinson’s Follow-up After Treatment in China: Prescriptions, Devices and Everyday Function at Home

The first review after returning home should examine whether the plan made in China works in ordinary life. An admission may involve limited activity and reminders to take medication; home brings work, stairs, shopping and getting up at night. Benefit can look different in that setting. Follow-up should therefore assess the original treatment goal, medication safety, equipment and the household’s ability to carry out the plan. NICE recommends continuing access to clinical monitoring, medication adjustment and reliable support. Those needs persist after an overseas visit ends. NICE recommendations on continuing care and support

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

  • Clarify the roles of the home neurologist, primary-care clinician and Chinese team. Who renews routine prescriptions? Who is contacted first about new dizziness or hallucinations? Who can change device settings, and who will interpret laboratory results? Assign these responsibilities to actual services rather than assuming that someone will take over. If the two teams suggest different changes, the patient should not follow both prescriptions simultaneously; ask the responsible clinician to reconcile them into one current plan.
  • Review actual use periods, skin or tube condition, alarms, day-to-day operation and whether medicine consumption matches the plan. If fatigue leads the patient or caregiver to miss a step repeatedly, report that openly. The team can only adapt support to difficulties it knows about. A form marked “using normally” is unhelpful when the household is struggling.
  • Sudden severe immobility with fever, marked rigidity or altered awareness, inability to take essential medicine, or rapid deterioration after device interruption warrants urgent local assessment. Akinetic crisis and related withdrawal syndromes can require hospital treatment. Waiting for a routine message response across time zones is inappropriate in that situation. Clinical guideline on akinetic crisis and withdrawal syndromes

Quick answer

The first review after returning home should examine whether the plan made in China works in ordinary life. An admission may involve limited activity and reminders to take medication; home brings work, stairs, shopping and getting up at night. Benefit can look different in that setting. Follow-up should therefore assess the original treatment goal, medication safety, equipment and the household’s ability to carry out the plan. NICE recommends continuing access to clinical monitoring, medication adjustment and reliable support. Those needs persist after an overseas visit ends. NICE recommendations on continuing care and support

Full guide

The first review after returning home should examine whether the plan made in China works in ordinary life. An admission may involve limited activity and reminders to take medication; home brings work, stairs, shopping and getting up at night. Benefit can look different in that setting. Follow-up should therefore assess the original treatment goal, medication safety, equipment and the household’s ability to carry out the plan. NICE recommends continuing access to clinical monitoring, medication adjustment and reliable support. Those needs persist after an overseas visit ends. NICE recommendations on continuing care and support

Agree who will make each decision

Clarify the roles of the home neurologist, primary-care clinician and Chinese team. Who renews routine prescriptions? Who is contacted first about new dizziness or hallucinations? Who can change device settings, and who will interpret laboratory results? Assign these responsibilities to actual services rather than assuming that someone will take over. If the two teams suggest different changes, the patient should not follow both prescriptions simultaneously; ask the responsible clinician to reconcile them into one current plan.

Prepare a brief account of what changed during the China visit: the original difficulty, investigations or procedures performed, the present interpretation and the questions still requiring observation. If the diagnosis was revised, explain the reason in the handover. List pending results and how they will be received. Lack of a message should not be interpreted as confirmation that every result was normal.

Check that the home service has accepted the information and can supply the agreed treatment. A discharge letter sent to an old address does not complete a handover. If a usual clinician is unavailable, identify the alternative route before routine medicine or technical support becomes urgent.

Reassess medication benefit in familiar surroundings

Keep the medication and symptom records requested by the team. Focus on whether the new regimen helps with the activities that motivated treatment, such as going out in the afternoon, washing independently or reducing nighttime assistance. Ask the caregiver to notice new involuntary movement, daytime sleepiness or behavioral change as well as tremor. Where difficulties relate to meals, sleep or dose timing, record the surrounding events.

The 2025 MDS evidence review considers multiple approaches to motor fluctuations. The existence of additional treatments does not mean that every difficult period requires immediate escalation. First establish actual use, tolerability and the symptom that matters to the patient, then discuss whether another change is justified. MDS evidence review of treatments for motor fluctuations

If the formulation used in China is unavailable locally, ask the clinician and pharmacist to verify a sustainable prescription. Similar names do not make different combinations, release systems or delivery routes interchangeable. Also confirm the schedule appropriate to local daily life rather than continuing a temporary time-zone transition plan indefinitely.

Be specific when describing a difference from the hospital result. “I can walk in the kitchen but freeze at the front door” gives the team more information than “the treatment failed.” Conversely, do not minimize a serious new problem because one original symptom improved. Follow-up needs both sides of that account.

Safety monitoring follows the exact medicine

In 2026 the FDA issued warnings about vitamin B6 deficiency and associated seizures for specified carbidopa/levodopa-containing products, with baseline, periodic and symptom-triggered assessment and supplementation when indicated. The handover should state whether assessment has occurred and which findings need review. The local clinician can then organize monitoring for the product actually being used. Patients should not independently stop treatment or begin long-term high-dose supplementation. FDA 2026 vitamin B6 safety communication

New blurred vision should not automatically be attributed to age or glasses. A 2026 pharmacovigilance analysis of amantadine-associated corneal edema highlights a potential reason for ophthalmic assessment. A case-based analysis cannot calculate an individual probability, but it can help clinicians recognize a problem. Give the eye specialist the complete medication list and describe the relationship between symptoms and treatment initiation. 2026 analysis of amantadine-associated corneal edema

Other monitoring depends on the prescription, additional conditions and symptoms. Distinguish having a test performed from having its result reviewed. If the laboratory or reference range changes, send the complete report rather than a number in a message. The follow-up record should explain what decision resulted, or why no change was needed.

DBS review concerns function as well as equipment

Keep the current settings, patient-controller instructions, charging routine and device identification available. When new speech difficulty, gait problems or dyskinesia occur, describe which medication and parameter changes preceded them. Saying only that the machine is broken can obscure a clinical problem that needs assessment. Not every difficulty can be solved by increasing stimulation. In three-year randomized follow-up, motor benefit, quality of life and cognitive trajectories did not all change together. DBS randomized follow-up at three years

Subsequent programming should be arranged with a team able to manage the actual system. For remote programming, confirm the supported country, equipment, connection and any necessary local assistance. An ordinary video call does not itself read or alter settings. When changing clinicians, supply the complete component history, including any replaced generator or lead, rather than just a brand card.

Observe the incision or overlying skin and note unusual charging or switching behavior. Persistent redness, discharge or pain warrants contact with the clinical team; systemic illness needs timely assessment. Before MRI or another procedure, the relevant professionals should verify the conditions for the patient’s complete implant. A previous scan does not establish that every future scanner setting is suitable.

There should also be a practical route for obtaining replacement accessories. Establish it while the system is working. If the patient depends on another person for charging, consider what happens during that caregiver’s illness or absence. A routine that works only when one person is always available may need additional support.

Infusion follow-up includes supplies and interruption planning

Review actual use periods, skin or tube condition, alarms, day-to-day operation and whether medicine consumption matches the plan. If fatigue leads the patient or caregiver to miss a step repeatedly, report that openly. The team can only adapt support to difficulties it knows about. A form marked “using normally” is unhelpful when the household is struggling.

The 2026 VYALEV label addresses local reactions, infection, operation and backup treatment when infusion is interrupted. After returning home, confirm that the authorized backup prescription remains obtainable, with an appropriate usable supply, and that the patient knows when to seek advice. Dose conversion should not be borrowed from another person’s experience online. VYALEV prescribing information, 2026

Check replenishment arrangements before the medicine or dedicated consumables run out. If a supply route changes, contact the treatment team early to discuss an alternative. A hope that a shipment may arrive is not a clinical interruption plan. Technical help from the device supplier also cannot replace medical evaluation of a patient who is deteriorating.

Adapt rehabilitation to the actual home

An activity that was manageable in hospital may remain difficult in a narrow bathroom, from a low sofa or in a dark corridor. Show the original training plan to a local therapist and describe the situations that fail most often. Safety, cueing and aids may need reassessment. Physical-therapy guidance supports interventions tied to movement, gait, balance and activity goals, with adjustment to individual needs. APTA Parkinson’s physical-therapy guideline

More exercise is not the only measure of success. Consider whether a task is safer, requires less help and leaves the person able to recover afterward. For falls and near falls, record the activity and environment. Repeating a hazardous movement alone to demonstrate progress can undermine the rehabilitation plan. Caregivers need to understand which tasks should be encouraged independently and which require assistance.

Discuss sustainability as well as technique. A lengthy program that the family cannot fit into daily life may need prioritization. Choose a small number of meaningful goals with the therapist and review whether practice produces useful change. Additional speech or occupational therapy may be necessary even when mobility improves.

Give swallowing, communication and mood their own goals

Persistent coughing with meals, weight loss or increasing difficulty taking tablets should prompt contact with the swallowing team. An earlier normal assessment does not rule out later change, and recommended food textures may need revision. The treatment consensus emphasizes multidisciplinary, individualized management rather than identical dietary restrictions for everyone. Consensus on treatment of dysphagia in Parkinson’s disease

For hallucinations or confusion, explain whether they are longstanding or appeared after travel, infection or a medication change. Relevant guidance recommends assessment of triggers and the overall clinical situation before careful medication decisions. Families should not add sedatives simply to make the patient quieter. Guideline on psychosis and delirium in Parkinson’s disease

Reduced voice volume, withdrawal from social contact or caregiver exhaustion also deserve explicit attention. A person may walk faster but still avoid leaving home because conversation is difficult. Keep these goals separate in the review so that professionals can identify the remaining support rather than interpreting motor improvement as resolution of every daily problem.

Use remote review for a defined task

Video discussion can help reconcile medication, observe some movements, explain reports and show aspects of the home environment. A 2017 randomized study found that specialist video visits added to usual care were feasible and reduced travel, but did not significantly improve the main quality-of-life outcome. It does not establish that video can replace every in-person assessment. Randomized trial of virtual visits for Parkinson’s disease

For a remote appointment, arrange clear lighting and sound and submit the current prescription and relevant observations beforehand. If walking will be shown, provide a safe space and assistance where needed. Do not attempt a pull test that could cause a fall without appropriate clinical supervision. Some examinations, wound treatment and urgent assessments require an in-person service. Whether cross-border care includes prescriptions, device changes or insurance billing must be confirmed with the actual provider.

Before the call ends, identify the next action, when it should happen and whether a local appointment or test is required. If the advice is to observe, clarify what to observe and what change would trigger earlier review. Write that down so that the household can tell whether the plan is still being followed.

Know when a local emergency service should take over

Sudden severe immobility with fever, marked rigidity or altered awareness, inability to take essential medicine, or rapid deterioration after device interruption warrants urgent local assessment. Akinetic crisis and related withdrawal syndromes can require hospital treatment. Waiting for a routine message response across time zones is inappropriate in that situation. Clinical guideline on akinetic crisis and withdrawal syndromes

Bring the current medication list and device information to the emergency service and explain recent treatment abroad. Once the urgent problem is stabilized, share the local findings with the Chinese team so that longer-term care can be coordinated. Routine review frequency can then reflect stability and treatment changes. It should not disappear because the patient returned home, nor does every review require another international flight.

An effective home plan tells the patient which prescription to follow today, what the next review is intended to resolve and where to seek help when circumstances change. The plan can evolve with the person’s needs. Connecting each practical problem to someone responsible for addressing it helps carry the benefit of a China consultation into ordinary family life.

Related guides